Tracking Dinakar Singh’s Axon Capital Portfolio – Q3 2018 Update

• Dinakar Singh’s 13F portfolio value decreased from $78M to $66M this quarter. 
• Axon Capital dropped Tyson Foods (TSN) and decreased Centene Group (CNC) & Allergan plc (AGN) during the quarter. The Stars Group (TSG) was increased significantly as well. 
• The largest three individual stock positions are The Stars Group (TSG), Playa Hotels (PLYA), and Centene, Corporation (CNC), and they add up to ~40% of the portfolio.

Dinakar Singh’s 13F portfolio value decreased ~16% from $78M to $66M this quarter. The portfolio is very concentrated with recent 13F reports showing just a handful of positions. The top five positions are Allergan plc, The Stars Group (TSG), Playa Hotels (PLYA), Centene Corp (CNC), Alphabet Inc. (GOOG), and McKesson Corporation (MCK). They add up to ~62% of the 13F portfolio.

Below is a summary:

Allergan plc (AGN): AGN is a large stake at ~9% of the entire 13F assets. The stake was established in Q3 2015 at prices between $279 and $331. Q2 2016 saw a ~38% increase at prices between $202 and $278 and that was followed with another ~20% increase the following quarter at prices between $231 and $260. Q4 2016 saw an about turn: ~85% reduction at prices between $189 and $243. The stock currently trades at $154. There was a ~17% trimming in Q2 2017 while the following quarter saw a one-third increase at prices between $202 and $256. There was a ~40% selling in Q4 2017 at prices between $164 and $211 while next quarter saw a ~21% increase. Last quarter saw a ~37% reduction at prices between $151 and $191 and that was followed with a ~50% selling this quarter at prices between $167 and $193.

Below is a spreadsheet that shows the changes to Dinakar Singh's Axon Capital 13F portfolio holdings as of Q3 2018. For a look at how the portfolio has progressed, see our previous update:

To learn more about how to profit from a strategy of following the best hedge fund picks, check out our book Profiting from Hedge Funds: Winning Strategies for the Little Guy .    

Tracking Dinakar Singh’s TPG-Axon Portfolio – Q2 2018 Update

·         Dinakar Singh’s 13F portfolio value decreased from $106M to $78M this quarter.

·         TPG-Axon dropped Time Warner and decreased Facebook, Allergan, Centene, and Alphabet during the quarter.

·         The largest three individual stock positions are Allergan, Centene, and The Stars Group and they add up to ~41% of the portfolio.

Dinakar Singh’s 13F portfolio value decreased ~27% from $106M to $78M this quarter. The portfolio is very concentrated with recent 13F reports showing just a handful of positions. The top five positions are Allergan plc, Centene, The Stars Group, Playa Hotels, and McKesson. They add up to ~64% of the 13F portfolio.

Below is a summary:

Allergan plc (AGN): AGN is currently the largest individual stock position at ~14% of the entire 13F assets. The stake was established in Q3 2015 at prices between $279 and $331. Q2 2016 saw a ~38% increase at prices between $202 and $278 and that was followed with another ~20% increase the following quarter at prices between $231 and $260. Q4 2016 saw an about turn: ~85% reduction at prices between $189 and $243. The stock currently trades at $183. There was a ~17% trimming in Q2 2017 while the following quarter saw a one-third increase at prices between $202 and $256. There was a ~40% selling in Q4 2017 at prices between $164 and $211 while last quarter saw a ~21% increase. This quarter saw a ~37% reduction at prices between $151 and $191.

Below is a spreadsheet that shows the changes to Dinakar Singh's TPG-Axon US long portfolio holdings as of Q2 2018. For a look at how the portfolio has progressed, see our previous update:

To learn more about how to profit from a strategy of following the best hedge fund picks, check out our book Profiting from Hedge Funds: Winning Strategies for the Little Guy .    

Tracking Dinakar Singh’s TPG-Axon Portfolio – Q1 2018 Update

• Dinakar Singh’s 13F portfolio value increased from $83M to $106M this quarter.
•  TPG-Axon increased Facebook, McKesson, and Alphabet during the quarter.
• The largest three individual stock positions are Allergan, Centene, and Time Warner and they add up to ~40% of the portfolio.

Dinakar Singh’s 13F portfolio value increased ~28% from $83M to $106M this quarter. The portfolio is very concentrated with recent 13F reports showing just a handful of positions. The top five positions are Allergan plc, Centene, Time Warner, Facebook, and McKesson. They add up to 62% of the 13F portfolio.

Below is a summary:

Allergan plc (AGN): AGN is currently the largest individual stock position at ~17% of the entire 13F assets. The stake was established in Q3 2015 at prices between $279 and $331. Q2 2016 saw a ~38% increase at prices between $202 and $278 and that was followed with another ~20% increase the following quarter at prices between $231 and $260. Q4 2016 saw an about turn: ~85% reduction at prices between $189 and $243. The stock currently trades at $169. There was a ~17% trimming in Q2 2017 while the following quarter saw a one-third increase at prices between $202 and $256. There was a ~40% selling last quarter at prices between $164 and $211 while this quarter saw a ~21% increase.

Below is a spreadsheet that shows the changes to Dinakar Singh's TPG-Axon US long portfolio holdings as of Q1 2018. For a look at how the portfolio has progressed, see our previous update:

To learn more about how to profit from a strategy of following the best hedge fund picks, check out our book Profiting from Hedge Funds: Winning Strategies for the Little Guy . 

Tracking Dinakar Singh’s TPG-Axon Portfolio – Q4 2017 Update

• Dinakar Singh’s 13F portfolio value decreased from $120M to $83M this quarter.
• TPG-Axon dropped Shire plc while adding Time Warner.
• The largest three individual stock positions are Allergan plc, Time Warner, and The Stars Group and they add up to ~45% of the portfolio.

Dinakar Singh’s 13F portfolio value decreased around one-third from $120M to $83M this quarter. The portfolio is very concentrated with recent 13F reports showing just a handful of positions. The top five positions are Allergan plc, Time Warner, The Stars Group, Equifax, and Centene and they add up to two-thirds of the 13F portfolio.

Below is a summary:

The Stars Group (TSG) previously Amaya Inc. (AYA): TSG is the third-largest stake at ~13% of the portfolio. The position was purchased over the four quarters thru Q1 2016 at prices between $10.50 and $28. Q4 2016 saw a ~26% reduction at prices between $13 and $17.50 and that was followed with a ~85% selling the following quarter at around the same price-range. Q2 2017 saw another ~30% selling at prices between $16.50 and $19.50. There was a ~9% increase last quarter while this quarter saw a ~38% reduction at prices between $20 and $24. The stock is currently at $27.35.

Allergan plc (AGN): AGN is currently the largest individual stock position at ~17% of the entire 13F assets. The stake was established in Q3 2015 at prices between $279 and $331. Q2 2016 saw a ~38% increase at prices between $202 and $278 and that was followed with another ~20% increase the following quarter at prices between $231 and $260. Q4 2016 saw an about turn: ~85% reduction at prices between $189 and $243. The stock currently trades at $164. There was a ~17% trimming in Q2 2017 while last quarter saw a one-third increase at prices between $202 and $256. There was a ~40% selling this quarter at prices between $164 and $211.

Below is a spreadsheet that shows the changes to Dinakar Singh's TPG-Axon US long portfolio holdings as of Q4 2017. For a look at how the portfolio has progressed, see our previous update:

To learn more about how to profit from a strategy of following the best hedge fund picks, check out our book Profiting from Hedge Funds: Winning Strategies for the Little Guy .    

Tracking Dinakar Singh’s TPG-Axon Portfolio – Q3 2017 Update

• Dinakar Singh’s 13F portfolio value increased from $89M to $120M this quarter.
• TPG-Axon reduced Equifax, Shire plc, Advanced Auto, and Ionis Pharma during the quarter.
• The largest three individual stock positions are Allergan plc, The Stars Group, and Equifax and they add up to ~50% of the portfolio.

Dinakar Singh’s 13F portfolio value increased around one-third from $89M to $120M this quarter. The portfolio is very concentrated with recent 13F reports showing just a handful of positions. The top five positions are Allergan plc, The Stars Group, Equifax, Shire plc, and McKesson Corp and they add up to ~73% of the 13F portfolio.

Below is a summary:

The Stars Group (TSG) previously Amaya Inc. (AYA): TSG is the second-largest stake at ~12% of the portfolio. The position was purchased over the four quarters thru Q1 2016 at prices between $10.50 and $28. Q4 2016 saw a ~26% reduction at prices between $13 and $17.50 and that was followed with a ~85% selling the following quarter at around the same price-range. Last quarter saw another ~30% selling at prices between $16.50 and $19.50. There was a ~9% increase this quarter. The stock is currently at $26.

Allergan plc (AGN): AGN is currently the largest individual stock position at ~25% of the entire 13F assets. The stake was established in Q3 2015 at prices between $279 and $331. Q2 2016 saw a ~38% increase at prices between $202 and $278 and that was followed with another ~20% increase the following quarter at prices between $231 and $260. Q4 2016 saw an about turn: ~85% reduction at prices between $189 and $243. The stock currently trades at $188. There was a ~17% trimming last quarter while this quarter saw a one-third increase at prices between $202 and $256.

Below is a spreadsheet that shows the changes to Dinakar Singh's TPG-Axon US long portfolio holdings as of Q3 2017. For a look at how the portfolio has progressed, see our previous update:

To learn more about how to profit from a strategy of following the best hedge fund picks, check out our book Profiting from Hedge Funds: Winning Strategies for the Little Guy .